CD4


Journal

The Journal of allergy and clinical immunology
ISSN: 1097-6825
Titre abrégé: J Allergy Clin Immunol
Pays: United States
ID NLM: 1275002

Informations de publication

Date de publication:
01 2021
Historique:
received: 13 02 2020
revised: 08 05 2020
accepted: 18 05 2020
pubmed: 3 6 2020
medline: 27 7 2021
entrez: 3 6 2020
Statut: ppublish

Résumé

IgG We sought to define CD4 Blood analyses were undertaken using flow cytometry, cell sorting, transcriptomic analyses at the population and single-cell levels, and next-generation sequencing for the TCR repertoire. Tissues were interrogated using multicolor immunofluorescence. Results were correlated with clinical data. We establish that among circulating CD4 CD4

Sections du résumé

BACKGROUND
IgG
OBJECTIVE
We sought to define CD4
METHODS
Blood analyses were undertaken using flow cytometry, cell sorting, transcriptomic analyses at the population and single-cell levels, and next-generation sequencing for the TCR repertoire. Tissues were interrogated using multicolor immunofluorescence. Results were correlated with clinical data.
RESULTS
We establish that among circulating CD4
CONCLUSIONS
CD4

Identifiants

pubmed: 32485263
pii: S0091-6749(20)30741-7
doi: 10.1016/j.jaci.2020.05.022
pmc: PMC7704943
mid: NIHMS1613315
pii:
doi:

Substances chimiques

Antigens, CD 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

368-382

Subventions

Organisme : NIAID NIH HHS
ID : U19 AI110495
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL150331
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI144295
Pays : United States
Organisme : NIAID NIH HHS
ID : K08 AI113163
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI060354
Pays : United States

Informations de copyright

Copyright © 2020 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Auteurs

Cory A Perugino (CA)

Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass; Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, Mass.

Naoki Kaneko (N)

Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass; Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.

Takashi Maehara (T)

Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass; Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.

Hamid Mattoo (H)

Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass; Immunology and Inflammation Therapeutic Area, Sanofi, Cambridge, Mass.

Jesper Kers (J)

Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass; Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute (AI&II), Amsterdam Cardiovascular Sciences (ACS), Amsterdam, The Netherlands; Van't Hoff Institute for Molecular Sciences (HIMS), University of Amsterdam, Amsterdam, The Netherlands.

Hugues Allard-Chamard (H)

Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass; Division of Rheumatology, Faculté de médecine et des sciences de la santé de l' Université de Sherbrooke et Centre de Recherche Clinique Étienne-Le Bel, Sherbrooke Québec, Canada.

Vinay S Mahajan (VS)

Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass; Department of Pathology, Brigham and Women's Hospital, Boston, Mass.

Hang Liu (H)

Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass; Department of Rheumatology and Immunology, First Hospital of China Medical University, Shenyang, China.

Emanuel Della-Torre (E)

Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass; Unit of Immunology, Rheumatology, Allergy, and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute, Milan, Italy.

Samuel J H Murphy (SJH)

Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass.

Musie Ghebremichael (M)

Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass.

Zachary S Wallace (ZS)

Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, Mass.

Marcy B Bolster (MB)

Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, Mass.

Liam M Harvey (LM)

Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, Mass.

Geetha Mylvaganam (G)

Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass.

Yesim Tuncay (Y)

Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass.

Lloyd Liang (L)

Division of Pulmonary & Critical Care Medicine, Massachusetts General Hospital, Boston, Mass.

Sydney B Montesi (SB)

Division of Pulmonary & Critical Care Medicine, Massachusetts General Hospital, Boston, Mass.

Xiuwei Zhang (X)

University of California, Berkeley, Calif.

Akira Tinju (A)

Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.

Keita Mochizuki (K)

Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.

Ryusuke Munemura (R)

Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.

Mizuki Sakamoto (M)

Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.

Masafumi Moriyama (M)

Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.

Seiji Nakamura (S)

Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.

Nir Yosef (N)

University of California, Berkeley, Calif.

John H Stone (JH)

Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, Mass.

Shiv Pillai (S)

Ragon Institute of MGH, MIT, and Harvard, Cambridge, Mass. Electronic address: pillai@helix.mgh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH